Carcinologic Speech Severity Index

Not Applicable

Completed

• Conditions: Head and Neck Cancer
• Interventions: Procedure: automatic speech processing tool

• Registration Number: NCT02875795
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

The hypothesis of the present study is that an automatic assessment technic can measure the impact of the speech disorders on the communication abilities giving a severity index of speech in patients treated for head and neck and particularly for oral and pharyngeal cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-01
• Study First Submitted: 2016-08-18
• Study First Submitted QC: 2016-08-22
• Study First Posted: 2016-08-23
• Primary Completion: 2017-12-31
• Study Completion: 2017-12-31
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-28
• Last Update Posted: 2020-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

• Oral and Pharyngeal cancer T2 to T4 for having a wide dynamic of deficit
• Treatment by surgery and/or radiotherapy and/or chemotherapy
• Delay after the end of the treatment of minimum 6 months.

Exclusion Criteria

• Patients with a previous speech disorders (ie stuttering... )
• Patients not able to perform the whole task

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
speech intelligibility	automatic speech processing tool	speech intelligibility is registered by an automatic speech processing tool

Primary Outcome Measures

Name	Time	Method
carcinologic speech severity index	day 0	The main objective is to demonstrate that the carcinologic speech severity index (C2SI), obtained by an automatic speech processing tool, produces equivalent or superior outcomes than a score of speech intelligibility obtained by human listeners, in terms of quality of life foreseeing the speech handicap, after the treatment of oral and/or pharyngeal cancer.